| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H15Cl2N3O |
| Molecular Weight | 324.205 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1CCN(CC1)C2=NN=C(C=C2)C3=CC=C(Cl)C=C3Cl
InChI
InChIKey=COWWILCLLRVLSC-UHFFFAOYSA-N
InChI=1S/C15H15Cl2N3O/c16-10-1-2-12(13(17)9-10)14-3-4-15(19-18-14)20-7-5-11(21)6-8-20/h1-4,9,11,21H,5-8H2
| Molecular Formula | C15H15Cl2N3O |
| Molecular Weight | 324.205 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Endixaprine (SR 41378 or 3-(4-hydroxy-1-piperidinyl)-6-(2,4-dichlorophenyl)-pyridazine) is a aminopyridazine derivative. Endixaprine is a nonbenzodiazepine compound with a pharmacological profile similar to barbiturates and benzodiazepines. It possesses anticonflict, anticonvulsant, antianxiety and hypnotic activities in rodents.
CNS Activity
Originator
Approval Year
PubMed
|
|
ACTIVE MOIETY |
Potential anticonvulsant
drug
|
Showing 1 to 1 of 1 entries